122 related articles for article (PubMed ID: 8100195)
1. Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist.
Kohli JD; Horn PT; Glock D; Brewster WK; Nichols DE
Eur J Pharmacol; 1993 Apr; 235(1):31-5. PubMed ID: 8100195
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
[TBL] [Abstract][Full Text] [Related]
4. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
[TBL] [Abstract][Full Text] [Related]
5. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
[TBL] [Abstract][Full Text] [Related]
7. FPL 63012AR: a potent D1-receptor agonist.
Smith GW; Farmer JB; Ince F; Matu K; Mitchell PD; Naya I; Springthorpe B
Br J Pharmacol; 1990 Jun; 100(2):295-300. PubMed ID: 1974159
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
[TBL] [Abstract][Full Text] [Related]
9. Social reactivity and D1 dopamine receptors: studies in mice selectively bred for high and low levels of aggression.
Lewis MH; Gariépy JL; Gendreau P; Nichols DE; Mailman RB
Neuropsychopharmacology; 1994 Apr; 10(2):115-22. PubMed ID: 7912934
[TBL] [Abstract][Full Text] [Related]
10. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.
Lovenberg TW; Brewster WK; Mottola DM; Lee RC; Riggs RM; Nichols DE; Lewis MH; Mailman RB
Eur J Pharmacol; 1989 Jul; 166(1):111-3. PubMed ID: 2572425
[No Abstract] [Full Text] [Related]
11. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
12. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia.
Mu Q; Johnson K; Morgan PS; Grenesko EL; Molnar CE; Anderson B; Nahas Z; Kozel FA; Kose S; Knable M; Fernandes P; Nichols DE; Mailman RB; George MS
Schizophr Res; 2007 Aug; 94(1-3):332-41. PubMed ID: 17596915
[TBL] [Abstract][Full Text] [Related]
13. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
Brewster WK; Nichols DE; Watts VJ; Riggs RM; Mottola D; Mailman RB
J Med Chem; 1995 Jan; 38(2):318-27. PubMed ID: 7830274
[TBL] [Abstract][Full Text] [Related]
15. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
Negash K; Nichols DE; Watts VJ; Mailman RB
J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
[TBL] [Abstract][Full Text] [Related]
16. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
17. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
Isacson R; Kull B; Wahlestedt C; Salmi P
Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
[TBL] [Abstract][Full Text] [Related]
18. A68930: a potent agonist selective for the dopamine D1 receptor.
DeNinno MP; Schoenleber R; MacKenzie R; Britton DR; Asin KE; Briggs C; Trugman JM; Ackerman M; Artman L; Bednarz L
Eur J Pharmacol; 1991 Jun; 199(2):209-19. PubMed ID: 1683288
[TBL] [Abstract][Full Text] [Related]
19. Dihydrexidine--the first full dopamine D1 receptor agonist.
Salmi P; Isacson R; Kull B
CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.
Luquin MR; Guillén J; Martínez-Vila E; Laguna J; Martínez-Lage JM
Eur J Pharmacol; 1994 Mar; 253(3):215-24. PubMed ID: 7911084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
